Actelion Confirms Approach by J&J About Possible Deal

Bloomberg Video

Nov.25 -- Swiss drugmaker Actelion Pharmaceuticals confirmed that it has been approached by Johnson & Johnson about a possible takeover. Bloomberg's Manuel Baigorri reports on "Bloomberg Markets: European Close."